Market entry partner · Tashkent, Uzbekistan

Your Gateway to the Uzbekistan Aesthetic Market

ALTEBIO was created to bring European aesthetic and medical brands to the Uzbekistan market — from registration and launch to professional training and sales growth.

37.5M Population
6.5% GDP growth, 2024
28 Median age
14 Regions covered

About ALTEBIO

A platform for European brands, built inside the market.

ALTEBIO is not a product catalogue. We are the operating partner that takes a European aesthetic or medical brand from the first conversation to registered, launched and growing in Uzbekistan.

Many international products have historically reached this market through fragmented and unofficial supply routes — without local registration, physician training or a partner accountable for the result. Brands had limited control over pricing, positioning and clinical reputation.

ALTEBIO was created to replace that route with a direct one: one exclusive partner, one documented supply chain, one team answering for the result.

One market. One accountable partner. One documented route.

Mission

To give every partner manufacturer a single accountable route into Uzbekistan — from regulatory dossier to sustainable sell-out.

Vision

To make Uzbekistan a standard destination on the expansion map of every serious European aesthetic brand.

Market

The largest, youngest and fastest-growing market in Central Asia.

37.5 million people, half of them under 30, in an economy that has grown around 6% a year since the 2017 reforms. Aesthetic medicine here is moving from a capital-city service to a nationwide category — and it is still under-supplied by European brands.

37.5M Population Largest in Central Asia, growing ~2% a year World Bank, 2024
6.5% GDP growth Sustained growth since the 2017 reforms World Bank, 2024
28 Median age More than half the population is under 30 UN Population Division, 2024
1,200+ Clinics & aesthetic centres Dermatology, cosmetology and plastic surgery ALTEBIO internal estimate, 2026
3,500+ Practising physicians The audience for education and KOL programmes ALTEBIO internal estimate, 2026
~20% Annual segment growth Injectables, devices and professional skincare ALTEBIO internal estimate, 2026
Market Tashkent Samarkand Bukhara Nukus Andijan Termez
14 regions covered 100+ Locations served

Macro indicators are based on national statistics and World Bank data for the year shown. Market figures marked as internal estimates are ALTEBIO assessments of the aesthetic segment and are refreshed with each annual review.

What we deliver

Everything a brand needs on the ground — under one contract.

You keep the product, the standards and the price architecture. We take responsibility for six areas that decide whether a brand succeeds in this market — each with a defined scope and a deliverable you receive.

01

Regulatory & Registration

Full regulatory route for devices, injectables and cosmeceuticals — from dossier review to Ministry of Health approval.

  • Dossier gap analysis
  • Document localisation and translation
  • Product registration
  • Certification and testing
  • Customs classification support

You receive: Registered product and a launch readiness report

02

Import & Distribution

One accountable partner per brand, a protected territory and a supply chain documented at every step.

  • Import operations and customs clearance
  • Certified storage conditions
  • Nationwide delivery
  • Clinic-level distribution
  • Stock and replenishment planning

You receive: A documented supply chain from your facility to the clinic

03

Market Entry Strategy

Positioning, pricing architecture and a first-year plan agreed before the first shipment leaves your warehouse.

  • Market and competitor assessment
  • Segment sizing for your category
  • Pricing architecture
  • Positioning and portfolio selection
  • Volume forecast and first-year plan

You receive: An agreed market entry plan with volumes and price levels

04

Marketing & Medical Communication

Launch campaigns, congress presence and medical communication built for the local professional audience — within your brand guidelines.

  • Launch campaign and brand rollout
  • Digital and professional channels
  • Congress and exhibition presence
  • Medical PR and publications
  • Localised materials approved by you

You receive: Brand presence built to your standards, with campaign reporting

05

Education & KOL Development

Certified trainings and a speaker programme that make your protocols the reference for physicians in this market.

  • Hands-on trainings and masterclasses
  • Protocol adaptation and certification
  • Speaker and faculty programmes
  • Opinion leader development
  • Congress scientific presence

You receive: Trained physicians and opinion leaders working to your protocols

06

Sales & Regional Growth

Key accounts, clinic chains and regional partners across Tashkent, twelve regions and Karakalpakstan — with sell-out reported back to you.

  • Key account development
  • Clinic chains and regional partners
  • Sell-in and sell-out tracking
  • Quarterly business reviews
  • Portfolio expansion planning

You receive: Quarterly sell-in and sell-out reporting with an agreed growth plan

Team experience

The experience ALTEBIO is built on.

Before ALTEBIO was founded, the team developed international aesthetic brands in Uzbekistan through Korestet and BNC Global: registering products, building the clinical network, training physicians and running industry events.

KORESTET BNC GLOBAL The companies through which the team worked in this market before ALTEBIO.
Caex Beauty Derma Central Asia - BNC Global 2025 participation
Caex Beauty Derma Central Asia - BNC Global 2025 participation
Master Class on “Face Lifting with Aestheline Threads”
Master Class on “Face Lifting with Aestheline Threads”
Workshop in South Korea with Dermatologists from Tashkent
Workshop in South Korea with Dermatologists from Tashkent
Master Class on “Skin Collagen Stimulation”
Master Class on “Skin Collagen Stimulation”

The projects, events and training programmes in this section were delivered by the team through Korestet and BNC Global before ALTEBIO was founded.

10+ years of combined team experience
25+ international brands previously developed by the team
300+ clinics in the professional network of the team
60+ events, trainings and congresses delivered by the team

Partnership Process

From first assessment to market growth, on a known path.

Eight stages, each with an owner on our side and a decision on yours. Months are counted from a signed agreement.

  1. M 0

    First Assessment

    Market briefing, portfolio review and a realistic volume assessment for your category.

  2. M 1

    Commercial Alignment

    Price levels, territory, targets and marketing commitments agreed by both sides.

  3. M 1–2

    Agreement

    Exclusive distribution agreement signed, with a defined scope and reporting cycle.

  4. M 2–4

    Regulatory Preparation

    Dossier gap analysis, document localisation, translation and testing plan.

  5. M 4–9

    Registration

    Submission, testing and Ministry of Health approval, tracked stage by stage.

  6. M 9–11

    Launch

    First shipment, pricing rollout, key-account presentations and launch communication.

  7. M 11+

    Education & Distribution

    Certified trainings in Tashkent and the regions, nationwide clinic coverage.

  8. M 12+

    Growth Review

    Volume, share and portfolio expansion reviewed with you every quarter.

Timelines are indicative and depend on product classification, dossier completeness and local testing requirements.